N-{5H,6H-benzo[h]quinazolin-2-yl}-3-(trifluoromethyl)benzamide

Catalog No. :
ACOQHP348
CAS No. :
306979-35-1
Molecular Formula :
C20H14F3N3O
Molecular Weight :
369.35

IUPAC Name:N-(5,6-dihydrobenzo[h]quinazolin-2-yl)-3-(trifluoromethyl)benzamide

N-{5H,6H-benzo[h]quinazolin-2-yl}-3-(trifluoromethyl)benzamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$323.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-{5H,6H-benzo[h]quinazolin-2-yl}-3-(trifluoromethyl)benzamide
IUPAC NameN-(5,6-dihydrobenzo[h]quinazolin-2-yl)-3-(trifluoromethyl)benzamide
MDL No.MFCD00231307
Molecular FormulaC20H14F3N3O
Molecular Weight369.35
SMILESO=C(NC1=NC=C2CCC3=CC=CC=C3C2=N1)C4=CC=CC(C(F)(F)F)=C4
InChI KeyCVEXTEYGVWGKFR-UHFFFAOYSA-N
SynonymN-(5,6-DIHYDROBENZO[H]QUINAZOLIN-2-YL)-3-(TRIFLUOROMETHYL)BENZENECARBOXAMIDE;N-{5H,6H-benzo[h]quinazolin-2-yl}-3-(trifluoromethyl)benzamide;Benzamide, N-(5,6-dihydrobenzo[h]quinazolin-2-yl)-3-(trifluoromethyl)-
CAS No.306979-35-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACOQHP348 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOQHP348 route product structure diagram
    ACOQHP348306979-35-1
Inquiry

2. ACOQHP348 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACHTIW589 route compound structure diagram
    ACHTIW589454-92-2 In Stock
  4. Then
  5. ACOQHP348 route product structure diagram
    ACOQHP348306979-35-1
Inquiry

Comments (0)